Research Report on Blood Glucose Monitoring Market

Research and Markets has declared that a new report titled "Blood Glucose Monitoring Market in the US 2011-2015" has been added to its portfolio.

According to the forecast by TechNavio's analysts, the Blood Glucose Monitoring Device market in the US will increase at a CAGR of 3.8% over the period 2011-2015. The launch of personal testing kits is one of the major factors fostering this market growth. Glucose monitoring systems has been adopted within the blood glucose monitoring device market in the US. This market growth can be hampered by diabetic patient’s aversion towards using blood glucose monitoring devices.

LifeScan, Bayer Healthcare, Roche Diagnostics, and Medtronic are the key vendors predominating in this market space. Other vendors in this report include Nova Biomedical, Abbott Laboratories, Braun Melsungen, Arkray, Nipro, Dexcom, GlySens, Diagnostics, Terumo, and Hainice Medical.

TechNavio's analyst stated that continuous glucose monitoring equipment having a transmitter and a sensor have been developed by vendors. The equipment is positioned within the body followed by interfacing with a wireless monitor that periodically receives the data. This equipment has been widely accepted by diabetic patients, thereby stimulating the growth of the Blood Glucose Monitoring (BGM) Device market in the US.

This report states that vendors have designed compact, portable BGM devices that are currently being commercialized in retail markets and pharmacies in the US. Vendors have started launching personal testing kits encompassing a bundle of test strips, BGM device, and other consumables, prevalent throughout the US.

Disclaimer: The views expressed here are those of the author expressed in their private capacity and do not necessarily represent the views of AZoM.com Limited T/A AZoNetwork the owner and operator of this website. This disclaimer forms part of the Terms and conditions of use of this website.